Meitheal Pharmaceuticals Inc. announced it has launched, through an exclusive license and supply agreement with its parent company, Hong Kong King-Friend Industry Co. Ltd., paclitaxel protein-bound particles for injectable suspension (albumin-bound), a generic form of Abraxane (Celgene) in the United States.
In a session about facing challenging nutritional scenarios in oncology patients, held at the ASPEN 2025 Nutrition Science & Practice Conference, in Columbus, Ohio, experts…
Pemgarda is well tolerated and appears effective in preventing symptomatic COVID-19 infection among patients with chronic lymphocytic leukemia (CLL), who can be severely immunocompromised, according…
New abstracts from investigators presented at MAD-ID 2025 provide more evidence of two-drug antibiotic combinations in patients with obesity.
Two new studies support the use of mailed fecal immunochemical colorectal cancer screening kits with follow-up to improve CRC screening.
The FDA has approved darolutamide (Nubeqa, Bayer Healthcare Pharmaceuticals) for metastatic castration-sensitive prostate cancer (mCSPC).
A structured exercise program after adjuvant chemotherapy in patients with high-risk stage II or III colon cancer improves both disease-free and overall survival, according to…
Two recent executive orders aim to increase U.S.-based pharmaceutical manufacturing and reduce drug prices, but both may need congressional action and could face legal challenges,…
Gastrointestinal immune-related adverse events (irAEs) are the most common AEs that lead to hospital admissions and readmissions in patients with genitourinary cancers prescribed immune checkpoint…
Over 300 million patient records were breached in 2024, a 26% increase from 2023
Pancreatic duct brush cytology and fluorescence in situ hybridization during endoscopic retrograde cholangiopancreatography were shown to be safe and have moderate accuracy for diagnosing pancreatic…
